Crinetics Pharmaceuticals, Inc.
Key Metrics
Market Snapshot
About
Crinetics Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for endocrine diseases and endocrine-related tumors. Headquartered in San Diego, California, the company is advancing a pipeline of small molecule therapeutics targeting rare and common endocrine disorders. Crinetics' lead product candidate, paltusotine, is being developed for acromegaly and carcinoid syndrome. The company's proprietary drug discovery platform focuses on G protein-coupled receptors (GPCRs).